Correlation Between Elicio Therapeutics and Zenas BioPharma,
Can any of the company-specific risk be diversified away by investing in both Elicio Therapeutics and Zenas BioPharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elicio Therapeutics and Zenas BioPharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elicio Therapeutics and Zenas BioPharma, Common, you can compare the effects of market volatilities on Elicio Therapeutics and Zenas BioPharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elicio Therapeutics with a short position of Zenas BioPharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elicio Therapeutics and Zenas BioPharma,.
Diversification Opportunities for Elicio Therapeutics and Zenas BioPharma,
-0.57 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Elicio and Zenas is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Elicio Therapeutics and Zenas BioPharma, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zenas BioPharma, Common and Elicio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elicio Therapeutics are associated (or correlated) with Zenas BioPharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zenas BioPharma, Common has no effect on the direction of Elicio Therapeutics i.e., Elicio Therapeutics and Zenas BioPharma, go up and down completely randomly.
Pair Corralation between Elicio Therapeutics and Zenas BioPharma,
Given the investment horizon of 90 days Elicio Therapeutics is expected to generate 1.26 times more return on investment than Zenas BioPharma,. However, Elicio Therapeutics is 1.26 times more volatile than Zenas BioPharma, Common. It trades about 0.03 of its potential returns per unit of risk. Zenas BioPharma, Common is currently generating about -0.1 per unit of risk. If you would invest 705.00 in Elicio Therapeutics on October 7, 2024 and sell it today you would lose (143.00) from holding Elicio Therapeutics or give up 20.28% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 15.93% |
Values | Daily Returns |
Elicio Therapeutics vs. Zenas BioPharma, Common
Performance |
Timeline |
Elicio Therapeutics |
Zenas BioPharma, Common |
Elicio Therapeutics and Zenas BioPharma, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Elicio Therapeutics and Zenas BioPharma,
The main advantage of trading using opposite Elicio Therapeutics and Zenas BioPharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elicio Therapeutics position performs unexpectedly, Zenas BioPharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zenas BioPharma, will offset losses from the drop in Zenas BioPharma,'s long position.Elicio Therapeutics vs. flyExclusive, | Elicio Therapeutics vs. Cheche Group Class | Elicio Therapeutics vs. Apogee Enterprises | Elicio Therapeutics vs. Aterian |
Zenas BioPharma, vs. FT Vest Equity | Zenas BioPharma, vs. Zillow Group Class | Zenas BioPharma, vs. Northern Lights | Zenas BioPharma, vs. VanEck Vectors Moodys |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |